Fitzsimons Innovation Community
Fitzsimon_menu

Find out what's happening on campus and across the industry.

Read Fitzsimons Innovation Community news, industry highlights, editorials, and innovation updates happening weekly on our campus.

News
Fitzsimons Innovation Community Selected as New Home for RefinedScience
November 12, 2024
Blog
RefinedScience: A Homegrown Success Story Finds a New Home at Fitzsimons Innovation Community
November 12, 2024
Blog
Change Please Brings Coffee with a Cause to Fitzsimons Innovation Community
October 31, 2024
Fitzsimons Innovation Community Selected as New Home for RefinedScience
News | Nov 12, 2024

Fitzsimons Innovation Community Selected as New Home for RefinedScience

Fitzsimons Innovation Community, an integrated campus of leading-edge facilities for innovative health and life sciences companies, announces RefinedScience, a Colorado high-tech biosciences company working to transform precision drug development, has selected the Community for its Colorado headquarters. To accelerate its path to market, RefinedScience will transition from The Foundry, a CU Innovations incubator housed in Bioscience 1, to permanent lab and office space in Bioscience 3 at Fitzsimons Innovation Community.

Lohocla Research Corp. Recognized as 2024 Colorado Inno Award Winner
News | Oct 28, 2024

Lohocla Research Corp. Recognized as 2024 Colorado Inno Award Winner

Colorado Inno Awards has selected Lohocla Research Corp as one of its 10 trailblazers making waves in the Colorado innovation ecosystem. Lohocla received FDA clearance in March for the first-in-human trials of a drug, Nezavist, intended to treat alcohol use disorder and craving. The company also received similar FDA clearance in October 2023 to move forward with Phase 1 trials of another drug it developed, Kindolor, to treat chronic pain.

Aurora mayor eyes redevelopment as catalyst to city's success
News | Oct 28, 2024

Aurora mayor eyes redevelopment as catalyst to city's success

Mike Coffman, City of Aurora Mayor and Fitzsimons Innovation Community Board Member, gave his annual State of the City address last week with a focus on maximizing the opportunity that exists with ongoing development of the CU Anschutz Medical Campus and the Fitzsimons Innovation Community.

Steve VanNurden Joins Denver Dealmakers Hall of Fame
News | Oct 28, 2024

Steve VanNurden Joins Denver Dealmakers Hall of Fame

Steve VanNurden, Fitzsimons Innovation Community President and CEO, was inducted into the Denver Dealmakers Hall of Fame, recognizing a class of dealmakers that has made an often-groundbreaking impact on their organizations, industries, and the region over the course of decades in business.

Here's How Denver Stacks up at Landing Company Headquarters
News | Oct 28, 2024

Here's How Denver Stacks up at Landing Company Headquarters

Metro Denver EDC hosted national site selectors to learn about Colorado’s competitive advantage. Adams County was highlighted for its opportunity to gain companies by providing data that shows how it is a more affordable community directly adjacent to the city of Denver.

OncoVerity CEO Featured in Pharmaceutical Executive’s Profiles in Medicine Series
News | Oct 04, 2024

OncoVerity CEO Featured in Pharmaceutical Executive’s Profiles in Medicine Series

With over three decades in biotech, Max Colao, CEO of OncoVerity, is at the forefront of personalized cancer treatment. In this compelling interview with Pharmaceutical Executive, Colao discusses his journey from industry giants to leading the startup OncoVerity in revolutionizing oncology care through computational biology and machine learning.

ClinImmune, RheumaGen Innovator Brian Freed Receives ASHI’s Highest Honor
News | Oct 04, 2024

ClinImmune, RheumaGen Innovator Brian Freed Receives ASHI’s Highest Honor

Brian Freed, Ph.D., Co-Founder & Chief Science Officer, RheumaGen, Executive Director, ClinImmune, and Professor of Medicine, University of Colorado will be recognized by the American Society of Histocompatibility & Immunogenetics (ASHI) with their highest honor.

GelSana Shares Vision for Innovative Would Care Solutions with Pharmaceutical Executive
News | Sep 18, 2024

GelSana Shares Vision for Innovative Would Care Solutions with Pharmaceutical Executive

In an interview with Pharmaceutical Executive, Melissa Krebs, Ph.D., the CEO and founder of GelSana, discusses her journey in developing novel biomaterials that aim to revolutionize the $78 billion wound care market

EnteroTrack: Tiny Capsule Could Be Game Changer in Gut Health
News | Sep 18, 2024

EnteroTrack: Tiny Capsule Could Be Game Changer in Gut Health

Denver’s 9News recently profiled a biotech entrepreneur leveraging a health innovation developed at Fitzsimons Innovation Community. Robin Shandas, founder and CEO of EnteroTrack, developed the swallowable capsule that collects microbiome samples. Using the capsule, UC Denver graduate student Alex Gregorian founded an early stage startup, BioWell, to make gut health insights more accessible.

Fitzsimons CEO Featured on Healthicity “Compliance Conversations” podcast to Discuss Groundbreaking Ideas Transforming the Future of Healthcare and Medicine
News | Sep 16, 2024

Fitzsimons CEO Featured on Healthicity “Compliance Conversations” podcast to Discuss Groundbreaking Ideas Transforming the Future of Healthcare and Medicine

Fitzsimons Innovation Community CEO Steve VanNurden spoke with CJ Wolfe, M.D., host of Healthicity "Compliance Conversations" podcast, to explore the unique integration of academic and entrepreneurial ecosystems, discuss the reinvention of tech transfer, and reveal the keys to building a thriving biotech community.

Fitzsimons Innovation Community Creates a Hub for Healthcare Tech
News | Aug 19, 2024

Fitzsimons Innovation Community Creates a Hub for Healthcare Tech

Fitzsimons Innovation Community President and CEO Steve VanNurden welcomed Dynamic Tech Media to campus for a conversation about the wrap-around support for our Community members and the growth of life sciences in our state.

GelSana Adds Commercialization Expertise with New Board Director, Diana Verrilli
News | Aug 12, 2024

GelSana Adds Commercialization Expertise with New Board Director, Diana Verrilli

GelSana welcomes Diana Verrilli, Chief Growth Officer at DispatchHealth, to the company’s Board of Directors. Diana, an accomplished healthcare leader brings extensive experience in commercialization and business strategy planning and execution.

Load More
© 2024

 Fitzsimons Innovation Community